Heidi Cuthbert

Gilead Sciences (NASDAQ:GILD) announced the deployment of an initial emergency donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda.

Jazz Pharmaceuticals (NASDAQ:JAZZ) announced top-line results from the Phase 3 LAGOON clinical trial evaluating Zepzelca (lurbinectedin) in patients with relapsed, second-line metastatic small cell lung cancer (SCLC).

Stellar’s cross-border payment network continues to gain attention as its anchor system links blockchain settlement with real-world remittance corridors across several major markets.

Kymera Therapeutics (NASDAQ:KYMR) reported positive findings from its Phase 1 clinical trial evaluating KT-621, a first-in-class oral small molecule STAT6 degrader, in healthy Japanese adults.

ArrowMark Financial (NASDAQ:BANX) declared its monthly cash distribution for June 2026, sustaining its consistent capital return schedule on the back of resilient quarterly earnings.

Brazilian Federal Deputy Jonas Donizette has introduced Bill 2946/2026, a proposal that would transform the country's existing cryptocurrency regulations into federal law and establish a permanent legal framework for virtual asset service providers.

LG Electronics is building a blockchain-based advertising platform on its own Arbitrum layer-2 network as the technology giant seeks to modernise how digital advertising inventory is bought, sold and measured.

Federal Court hits collapsed CFD issuer Union Standard and its representatives with a record $300.2 million ASIC penalty.

Cardano is approaching a key regulatory milestone that could strengthen its case for a US spot exchange-traded fund as the cryptocurrency nears the SEC's six-month futures-market requirement.

Advanced artificial intelligence models have created a “vulnerability apocalypse” for the cryptocurrency industry by making it easier for attackers to identify and exploit weaknesses in decentralised finance protocols, according to Immunefi chief executive Mitchell Amador.